CGI image of the Coronavirus

COVID-19 and Medical Imaging

Information Matters

Transparent information and working together are the strongest response to the constantly changing demands of this challenging situation. That is why we have consolidated relevant publications and society statements to answer questions on the role of imaging in COVID-19 disease characterization and disease management.

The compiled information on COVID-19 is rapidly evolving, thus the information presented below is current as of mid-May 2020 and subject to periodic updates.

FAQs

In order to solve a problem, we must first understand it. Here we offer current answers to the relevant questions we have about COVID-19.

View All FAQs
close up of women on train platform wearing a medical face mask
icon of a MRI scanner, document and shield

Radiology Society Recommendations

Collaboration and communication are powerful weapons in the fight against COVID-19. We have collated the positions and statements of world leading radiology societies.

Find Out More

Device Disinfection

Proper cleaning and disinfection of medical devices has never been more important. We recommend following these instructions.

View Instructions
close up of three MEDRAD® injector
icon of a binder, lungs and attention symbol

Relevant Publications

Conclusive evidence is key to understand the role of imaging. Here we present an overview of publications related to COVID-19 and imaging and summarized the most relevant ones.

Find Out More

Our Commitment during the Coronavirus Pandemic

We are contributing to the global fight against the coronavirus through our products and expertise in health and nutrition. Our Corona ticker provides an up-to-date overview of our activities.

Stay Updated

Any individuals depicted on this web page are actors and not actual health care providers or patients.
Patient Information listed on the Graphical User Interfaces are fictitious examples only and do not contain any actual patient data.

MRI images throughout this website are actual patient cases but all personal identifiers have been removed or otherwise anonymized. No personally identifiable information is shown.

You are encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

© 2020-2023 Bayer

BAYER, the Bayer Cross, MEDRAD Stellant, MEDRAD MRXperion, MEDRAD Stellant FLEX, MEDRAD XDS, MEDRAD Veris, MEDRAD Stellant P3T, MEDRAD Spectris Solaris, MEDRAD Spectris, MEDRAD Mark 7 Arterion, MEDRAD Mark V ProVis, MEDRAD Intego, MEDRAD Avanta, MEDRAD Twist & Go, MEDRAD VFlow, Certegra P3T, MEDRAD FluiDots, MEDRAD Vistron, MEDRAD Envision, MEDRAD Certo, MEDRAD, Stellant, MRXperion, Stellant FLEX, Veris, Spectris Solaris, Spectris, Mark 7 Arterion, Mark V ProVis, Avanta, Envision, Twist & Go, VFlow, Radimetrics, Certegra, P3T, Seamlessly Smart, DirectCARE, PartnerCARE, VirtualCare, SelectCARE, and TechCARE are trademarks owned by and/or registered to Bayer in the U.S. and/or other countries.

Bayer HealthCare LLC 100 Bayer Boulevard, PO Box 915, Whippany, NJ 07981

Last update: February 2023

Bayer-logo-white